1. Turnheim K. Drug therapy in the elderly. Exp Gerontol 2004; 39: 1731–1738.
2. Bressler R, Bahl JJ. Principles of drug therapy for the elderly patient. Mayo Clin Proc 2003; 78: 1564–1577.
4. Williams CM. Using medications appropriately in older adults. Am Fam Phys 2002; 66: 1917–1924.
5. Wooten J, Galavis J. Polypharmacy: keeping the elderly safe. RN 2005; 68: 44–51.
7. Drug therapy considerations in older adults. Health Notes 2003; 1: 5–53.
8. McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 2004; 56: 163–184.
9. Chaurasia RN, Singh AK, Gambhir IS. Rational drug therapy in elderly. J Indian Acad Geriatr 2005; 2: 82–88.
10. Roehl B, Talati A, Parks S. Medication prescribing for older adults. Ann Long-Term Care 2006; 14: 33–39.
11. Petrone K, Katz P. Approaches to appropriate drug prescribing for the older adult. Prim Care Clin Office Pract 2005; 32: 755–775.
13. Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol 2007; 21: 217–230.
14. Hutchison LC, O’Brien CE. Changes in pharmacokinetics and pharmacodynamics in the elderly patient. J Pharm Prac 2007; 20: 4–12.
15. Miller SW. Therapeutic drug monitoring in the geriatric patient. In: Murphy JE, ed. Clinical Pharmacokinetics. 4th ed. Bethesda, MD: American Society of Health-System Pharmacists; 2007: chap 23.
16. Ferrario CG. Geropharmacology: a primer for advanced practice acute care and critical care nurses, part I. AACN Adv Crit Care 2008; 19: 23–37.
17. Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol 2004; 57: 6–14.
18. Greenblatt DJ, von Moltke LL, Harmatz JS, et al. Pharmacokinetics, pharmacodynamics, and drug disposition. In: Davis KL, Charney D, Coyle JT, et al., eds. Neuropsychopharmacology: The Fifth Generation of Progress. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2002: 507–524.
19. Kapadia A, Wynn D, Salzman B. Potential adverse effects of proton pump inhibitors in the elderly. Clin Geriatr 2010; 18: 24–31.
20. Richardson MM. Precision versus approximation: the trade off in assessing kidney function and drug dosing. Pharmacotherapy 2010; 30: 758–761.
21. Nyman HA, Dowling TC, Hudson JQ, et al. Comparative evaluation of the Cockcroft-Gault equation and the modification of diet in renal disease (MDRD) study equation for drug dosing. Pharmacotherapy 2011; 31: 1130–1144.
22. Merle L, Laroche ML, Dantoine T, et al. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 2005; 22: 375–392.
23. Routledge PA, O’Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004; 57: 121–126.
24. Gray CL, Gardner C. Adverse drug events in the elderly: an ongoing problem. J Manag Care Pharm 2009; 15: 568–571.
25. Snyder S, Pendergraph B. Detection and evaluation of chronic kidney disease. Am Fam Phys 2005; 72: 1723–1734.
26. Amarapurkar DN. Prescribing medications in patients with decompensated liver cirrhosis. Int J Hepatol 2011; 11: 1–5.
27. Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother 2007; 5: 263–303.
28. Wang L. Epidemiology and prevention of adverse drug reactions in the elderly. J Geriatr Cardiol 2005; 2: 248–253.
29. Mendes-Nett RS, Silva CQ, Oliveira Filho AD, et al. Assessment of drug interactions in elderly patients of a family health care unit in Aracaju (Brazil): a pilot study. Afr J Pharm Pharmacol 2011; 5: 812–818.
30. Grattagliano I, Portincasa P, D’Ambrosio G, et al. Avoiding drug interactions: here’s help. J Fam Pract 2010; 59: 322–329.
31. Lin P. Drug interactions and polypharmacy in the elderly. Can Alzheimers Dis Rev 2003; 6: 10–14.
32. Steinman MA, Handler SM, Gurwitz JH, et al. Beyond the prescription: medication monitoring and adverse drug events in older adults. J Am Geriatr Soc 2011; 59: 1513–1520.
33. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012; 10: 1532–1541.
34. Baker DW, Wolf MS, Feinglass J, et al. Health literacy and mortality among elderly persons. Arch Intern Med 2007; 167: 1503–1509.
35. Weiss BD. Health Literacy and Patient Safety: Help Patients Understand: A Manual for Clinicians. Chicago: American Medical Association; 2007.
36. Hamilton H, Gallagher P, Ryan C, et al. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med 2011; 171: 1013–1019.